Patent US1514245A successfully refreshed from Google Patents.
Patent EP0001715A2 successfully refreshed from Google Patents.
EP0001715A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Azetidinone antibiotics and their pharmaceutical formulations and use
Assignee: Eli Lilly and Co
•
Filing: 1978-10-24
•
Granted: —
•
Expires: 1998-10-24
Abstract
Abstract Novel 3-acylaminoazetidin-4- one compounds of the general formula wherein R 2 is a group of the formula wherein R is a hydrogen atom o: a carboxylic acid ester protecting group and X is C 1 -C 3 acyloxy h,droxy. C 1 -C 4 alkoxy, benzyloxy, or pyridinium; and wherein R 1 is hydrogen or an acyl group; and the phar. maceutically acceptable salts thereof, are described herein which novel compounds are useful as antimicrobial agents.
Inventors
- 👤 David Kent Herron
- 👤 Celia Ann Whitesitt
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-09 04:58
CPC Classifications
C; C07; C07D; C07D205/00; C07D205/02; C07D205/06; C07D205/08; C07D205/085; A; A61; A61P; A61P31/00; A61P31/04; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
226 words
A compound of the general formula wherein R 2 is a group of the formula wherein R is a hydrogen atom or a carboxylic acid ester protecting group and X is C 1 -C 3 acyloxy, hydroxy, C l -C 4 alkoxy, benzyloxy, or pyridinium; and wherein R i is hydrogen or an acyl group of the formula wherein R 5 is (a) hydrogen, C 1 -C 4 alkyl, halomethyl or phenyl; (b) benzyloxy, 4-nitrobenzyloxy, 2,2,2-trichloroethoxy, tert-butoxy, or 4-methoxybenzyloxy; (c) an arylalkyl group of the formula R 6 -(O) m -CH 2 - wherein m is 0 or 1 and R 6 is 1,4-cyclo- hexadienyl, phenyl or phenyl substituted with 1 or 2 substituents independently selected from the group consisting of halo, hydroxy, nitro, cyano, trifluoromethyl, C 1 -C 4 alkyl and C l -C 4 alkoxy; (d) a substituted arylalkyl group of the formula wherein R 7 is R 6 as defined above, 2-thienyl or 3-thienyl and W is hydroxy, protected hydroxy, carboxy, protected carboxy, amino, protected amino or a group of the formula or (e) a heteroaryl methyl group of the formula wherein R 8 is 2-thienyl, 3-thienyl, 2-furyl, 2-thiazolyl, 5-tetrazolyl, 1-tetrazolyl or 4-isoxazolyl, and when R 1 is hydrogen, the hydrochloride acid addition salts of the amines represented thereby, and when R is hydrogen the pharmaceutically acceptable salts of the acids represented thereby.
Claim 2
Dependent Claim
226 words
A compound of the general formula wherein R 2 is a group of the formula wherein R is a hydrogen atom or a carboxylic acid ester protecting group and X is C 1 -C 3 acyloxy, hydroxy, C l -C 4 alkoxy, benzyloxy, or pyridinium; and wherein R i is hydrogen or an acyl group of the formula wherein R 5 is (a) hydrogen, C 1 -C 4 alkyl, halomethyl or phenyl; (b) benzyloxy, 4-nitrobenzyloxy, 2,2,2-trichloroethoxy, tert-butoxy, or 4-methoxybenzyloxy; (c) an arylalkyl group of the formula R 6 -(O) m -CH 2 - wherein m is 0 or 1 and R 6 is 1,4-cyclo- hexadienyl, phenyl or phenyl substituted with 1 or 2 substituents independently selected from the group consisting of halo, hydroxy, nitro, cyano, trifluoromethyl, C 1 -C 4 alkyl and C l -C 4 alkoxy; (d) a substituted arylalkyl group of the formula wherein R 7 is R 6 as defined above, 2-thienyl or 3-thienyl and W is hydroxy, protected hydroxy, carboxy, protected carboxy, amino, protected amino or a group of the formula or (e) a heteroaryl methyl group of the formula wherein R 8 is 2-thienyl, 3-thienyl, 2-furyl, 2-thiazolyl, 5-tetrazolyl, 1-tetrazolyl or 4-isoxazolyl, and when R 1 is hydrogen, the hydrochloride acid addition salts of the amines represented thereby, and when R is hydrogen the pharmaceutically acceptable salts of the acids represented thereby.
Claim 3
Dependent Claim
14 words
The compound of claim 1 wherein R 2 is a group of the formula
Claim 4
Dependent Claim
10 words
The compound of claim 2 wherein R 1 is hydrogen.
Claim 5
Dependent Claim
14 words
The compound of claim 1 wherein R 2 is a group of the formula
Claim 6
Dependent Claim
10 words
The compound of claim 4 wherein R 1 is hydrogen.
Claim 7
Dependent Claim
12 words
The compound of claim 1 wherein R is tert-butyl, 4-methoxybenzyl or diphenylmethyl.
Claim 8
Dependent Claim
13 words
The compound of claim 4 wherein X is C 1 -C 4 alkoxy.
Claim 9
Dependent Claim
9 words
The compound of claim 4 wherein X is hydroxy.
Claim 10
Dependent Claim
9 words
The compound of claim 4 wherein X is pyridinium.
Claim 11
Dependent Claim
40 words
Any one of the following compounds: benzhydryl 2-(3-phenoxyacetamido-2- oxoazetidin-1-yl)-5-methyl-3-butenoate benzhydryl 2-(3-phenoxyacetamido-2- oxoazetidin-1-yl)-3-methyl-4-methoxy-2-butenoate 2-(3-phenoxyacetamido-2-oxoazetidin-1-yl)-3-methyl-4-methoxy-2-butenoic acid benzhydryl 2-(3-amino-2-oxoazetidin-l-yl)-3-methyl-4-methoxy-2-butenoate hydrochloride benzhydryl 2-[3-[D-2-(4-hydroxyphenyl)-2-tert-butoxycarbonylaminoacetamido]-2-oxoazetidin-1-yl]-3-methyl-4-methoxy-2-butenoate 2-[3-[D-2-(4-hydroxyphenyl)-2-aminoacetamido]-2-oxoazetidin-l-yl]-3-methyl-4-methoxy-2-butenoic acid trifluoroacetic acid salt benzhydryl 2-(3-phenoxyacetamido-2- oxoazetidin-1-yl)-3-methyl-4-formyloxy-2-butenoate benzhydryl 2-(3-phenoxyacetamido-2-oxo- azetidin-1-yl)-3-methyl-4-hydroxy-2-butenoate 2-[3-[D-2-(4-hydroxyphenyl)-2-[(N,N'- dimethylureido)carbonylamino]acetamido]-2-oxoazetidin-1-yl]-3-methyl-4-methoxy-2-butenoic acid benzhydryl 2-(3-phenoxyacetamido-2- oxoazetidin-l-yl)-3-methyl-4-pyridinium-2-butenoate bromide 2-(3-phenoxyacetamido-2-oxoazetidin-1-yl)-3-methyl-4-pyridinium-2-butenoic acid trifluoroacetate
Claim 12
Dependent Claim
40 words
Any one of the following compounds: benzhydryl 2-(3-phenoxyacetamido-2- oxoazetidin-1-yl)-5-methyl-3-butenoate benzhydryl 2-(3-phenoxyacetamido-2- oxoazetidin-1-yl)-3-methyl-4-methoxy-2-butenoate 2-(3-phenoxyacetamido-2-oxoazetidin-1-yl)-3-methyl-4-methoxy-2-butenoic acid benzhydryl 2-(3-amino-2-oxoazetidin-l-yl)-3-methyl-4-methoxy-2-butenoate hydrochloride benzhydryl 2-[3-[D-2-(4-hydroxyphenyl)-2-tert-butoxycarbonylaminoacetamido]-2-oxoazetidin-1-yl]-3-methyl-4-methoxy-2-butenoate 2-[3-[D-2-(4-hydroxyphenyl)-2-aminoacetamido]-2-oxoazetidin-l-yl]-3-methyl-4-methoxy-2-butenoic acid trifluoroacetic acid salt benzhydryl 2-(3-phenoxyacetamido-2- oxoazetidin-1-yl)-3-methyl-4-formyloxy-2-butenoate benzhydryl 2-(3-phenoxyacetamido-2-oxo- azetidin-1-yl)-3-methyl-4-hydroxy-2-butenoate 2-[3-[D-2-(4-hydroxyphenyl)-2-[(N,N'- dimethylureido)carbonylamino]acetamido]-2-oxoazetidin-1-yl]-3-methyl-4-methoxy-2-butenoic acid benzhydryl 2-(3-phenoxyacetamido-2- oxoazetidin-l-yl)-3-methyl-4-pyridinium-2-butenoate bromide 2-(3-phenoxyacetamido-2-oxoazetidin-1-yl)-3-methyl-4-pyridinium-2-butenoic acid trifluoroacetate
Claim 13
Dependent Claim
30 words
A pharmaceutical formulation comprising a compound of formula (I) as claimed in any one of claims 1 to 10, or a pharmaceutically-acceptable salt thereof, together with a pharmaceutically-acceptable carrier therefor.
Claim 14
Dependent Claim
20 words
A compound of formula (I) as claimed in any one of claims 1 to 10 for use as an antibacterial.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.